市場調査レポート
商品コード
1410842
アテレクトミーデバイス市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年)Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
アテレクトミーデバイス市場:市場規模(セグメント別)、シェア、規制、償還、手技、予測(~2033年) |
出版日: 2023年12月21日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
冠動脈疾患(CAD)は、発展途上国および先進国における世界の負担として浮上しています。末梢動脈疾患(PAD)は世界の公衆衛生および社会経済問題であり、毎年数百万人の患者に影響を及ぼしています。世界的にCADとPADの有病率が増加しているのは、糖尿病、高血圧、肥満、タバコの使用などの危険因子や併存疾患のためです。
全体として、都市化が喫煙率の増加、運動不足、不健康なライフスタイルを招いています。さらに、これらの併存疾患の多くは年齢と密接に結びついているため、高齢者人口の増加も疾患有病率の上昇に寄与しています。
当レポートは、世界のアテレクトミーデバイス市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Atherectomy Devices market for the year 2020 and beyond. Coronary Artery Disease (CAD) has emerged as a global burden on developing and developed countries. Peripheral artery disease (PAD) is a global public health and socioeconomic problem affecting millions of patients each year. The increasing prevalence of both CAD and PAD worldwide can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use.
Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Atherectomy Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Cardiovascular Systems Inc, Boston Scientific Corp, Koninklijke Philips NV, Medtronic Plc, Avinger Inc, Becton Dickinson and Co, Angiodynamics Inc.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable